USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: CEL-SCI CORPORATION
City: VIENNA
State: VA
Zip+4: 22182
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: http://www.cel-sci.com
Phone: (703) 506-9460

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $500,692.00 5
SBIR Phase II $379,053.00 1

Award List:

HETEROCONJUGATE VACCINES AGAINST HERPES SIMPLEX VIRUS

Award Year / Program / Phase: 1998 / SBIR / Phase I
Agency: HHS
Principal Investigator: Zimmerman, Daniel H
Award Amount: $100,000.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Daniel H. Zimmerman
Award Amount: $0.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase II
Agency: HHS
Principal Investigator: Daniel H. Zimmerman
Award Amount: $379,053.00

Augmenting innate and vaccine immune response with der-G

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Daniel H. Zimmerman
Award Amount: $104,091.00
Abstract:
DESCRIPTION (provided by applicant): Concerns regarding the United States' vulnerability to a terrorist attack with smallpox have stimulated development of new vaccines, prophylactics and therapeutics. However, a new and successful smallpox vaccine intervention program, or one to treat exposed… More

derG Immunostimulant Prevention/Treatment of HSV Disease

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Daniel H. Zimmerman
Award Amount: $162,132.00
Abstract:
DESCRIPTION (provided by the applicant): The goal of this program is to develop derG as a therapeutic and/or prophylactic agent for HSV infections. DerG is a small peptide shown in preliminary experiments to elicit anti-viral and anti-parasitic (malarial) responses, and adjuvant activity. Based… More

Peptide Vaccine for Experimental Autoimmune Myocarditis

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Daniel H. Zimmerman
Award Amount: $134,469.00
Abstract:
DESCRIPTION (provided by the applicant): In A/J Mice Experimental Autoimmune Myocarditis (EAM) can be induced by infection with coxsackie virus B 3 or by immunization with murine or porcine cardiac myosin or a cardiogenic peptide from the murine cardiac myosin (My-l). In all these three cases the… More